Filtros de búsqueda

Lista de obras de

Abstract 2574: Interleukin-7 (CYT107) treatment in lymphopenic 1stline metastatic breast carcinoma patients treated with chemotherapy regimen (Capecitabine) favors the restoration of T-cell subsets number

CD4 lymphopenia to identify end-of-life metastatic cancer patients

artículo científico publicado en 2012

Discontinuation of imatinib in patients with advanced gastrointestinal stromal tumours after 3 years of treatment: an open-label multicentre randomised phase 3 trial.

artículo científico publicado en 2010

Efficacy of trabectedin for advanced sarcomas in clinical trials versus compassionate use programs: analysis of 92 patients treated in a single institution

artículo científico publicado en 2010

Long term term follow-up of tyrosine kinase inhibitors treatments in inoperable or relapsing diffuse type tenosynovial giant cell tumors (dTGCT)

scientific article published on 20 May 2020

Long-term outcome of molecular subgroups of GIST patients treated with standard-dose imatinib in the BFR14 trial of the French Sarcoma Group

artículo científico publicado en 2015

Lymphopenia as a prognostic factor for overall survival in advanced carcinomas, sarcomas, and lymphomas

artículo científico publicado en 2009

Lymphopenia combined with low TCR diversity (divpenia) predicts poor overall survival in metastatic breast cancer patients.

artículo científico publicado en 2012

Prospective multicentric randomized phase III study of imatinib in patients with advanced gastrointestinal stromal tumors comparing interruption versus continuation of treatment beyond 1 year: the French Sarcoma Group.

artículo científico publicado en 2007

Validation of prognostic scores for survival in cancer patients beyond first-line therapy

artículo científico publicado en 2011

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda